Skip to main content

Day One Biopharmaceuticals, Inc.

DAWNDelisted Apr 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001845337

Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of DAWN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1401130−9
Shares78.8M11.5K77.5M−1.25M (−1.6%)
Value$941.0M$137.0K$951.5M+$10.6M (+1.1%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to DAWN in Q3 2023
InstitutionSharesValue% of portfolio
Pictet Asset Management Holding SA600,039$7.36M0.01%
Walleye Capital LLC277,206$3.40M0.05%
Simplify Asset Management Inc.175,018$2.15M0.35%
Trexquant Investment LP97,868$1.20M0.03%
Walleye Trading LLC14,966$183.6K0.00%
Capstone Investment Advisors, LLC11,088$136.1K0.00%
Quarry LP6,519$80.0K0.05%
Group One Trading, L.P.2,958$36.3K0.00%
Comerica Bank206$2.53K0.00%
IFP Advisors, Inc24$2940.00%
Northwestern Mutual Wealth Management Co15$1840.00%
The PNC Financial Services Group, Inc.4$490.00%
Avion Wealth37$00.00%

Sold out (22)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DAWN in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
PFS Investments Inc.11,505$137.0K